Third Wave seeks pre-market approval for HPV testing technology
The submission of two pre-market applications to the Food and Drug Administration for human papillomavirus, or HPV tests, is based on the strength of clinical trial data, according to Third Wave Technologies. The Madison biotechnology company expects to be on the market with the HPV...